drugset
drugset / Trial / NCT06974292

The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers

NCT06974292 ↗

Phase 1 Completed 6 enrolled Jiangsu vcare pharmaceutical technology co., LTD
NaSingle-groupOpen-labelTreatment

Summary

This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]VC005 orally in Chinese healthy male volunteers.

Timeline

Start
2025-05-26
Primary completion
2025-06-03
Completion
2025-06-03

Drugs

EvaluationDrugModalityDoseRoute
Subject VC005 Unknown 50 mg Oral

Indications

atopic eczema